In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols

Journal of Clinical Investigation

Volumn 94, Issue 4, 1994, Pages 1432-1439

  Scharfstein, Jonathan S ^c   Keaney Jr , John F ^a   Slivka, Adam ^c   Welch, George N ^c   Vita, Joseph A ^a   Stamler, Jonathan S ^b   Loscalzo, Joseph ^a,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

endothelium derived relaxing factor; nitric oxide; proteins; S nitrosothiols; thiols

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; SERUM ALBUMIN; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTENSION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TRANSPORT; RABBIT; STATISTICAL ANALYSIS;

EID: 0028001444     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117480     Document Type: Article

References (43)

1. Furchgott, R. F., and J. V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.). 288:373-376.
2. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature (Lond.). 327:524-526.
3. Furchgott, R. F. 1983. Role of endothelium in responses of vascular smooth muscle. Circ. Res. 35:557-573.
4. Ignarro, L. J., R. E. Byrns, G. M. Buga, and K. S. Wood. 1987. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 61:866-879.
5. Mellion, B. T., L. J. Ignarro, E. H. Ohlstein, E. G. Pontecorvo, A. L. Hyman, and P. J. Kadowitz. 1981. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57:946-955.
6. Radomski, R. A., R. M. J. Palmer, and S. Moncada. 1987. Comparative physiology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets. Br. J. Pharmacol. 92:181-187.
7. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1986. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-1058.
8. Radomski, M. W., R. M. K. Palmer, and S. Moncada. 1987. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148:1482-1489.
9. Ignarro, L. J., G. M. Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:9265-9269.
10. Buga, G. M., M. E, Gold, K. S. Wood, G. Chaudhuri, and L. J. Ignarro. 1989. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. Eur. J. Pharmacol. 161:61-72.
11. Shikano, K., C. J. Long, E. H. Ohlstein, and B. A. Berkowitz. 1988. Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide. J. Pharm. Exp. Ther. 247:873-881.
12. Myers, P. R., R. L. Minor, Jr., R. Guerra, Jr., J. N. Bates, and D. G. Harrison. 1990. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature (Lond.) 345:161-163.
13. Kelm, M., and J. Schrader. 1990. Control of coronary vascular tone by nitric oxide. Circ. Res. 66:1561-1575.
14. Ignarro, L. J., H. Lipton, J. C. Edwards, W. H. Barricos, A. L. Hyman, P. J. Kadowitz, and C. A. Greutter. 1981. Mechanism of vascular smooth muscle relaxation by organic nitrates, sodium nitroprusside, and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:739-749.
15. Ignarro, L. J., J. C. Edwards, D. Y., Greutter, B. K. Barry, and C. A. reutter. 1980. Possible involvement of S-nitrosothiols in the activation of guanyl-cyclase by nitroso compounds. FEBS (Fed. Eur. Biochem. Soc.) Lett. 11:275-78.
16. Oae, S., Y. H. Kim, D. Fukushima, and K. Shinhama. 1978. New synthesis of thionitrites and their chemical reactivities. J. Chem. Soc. Perkin Trans. I, 913-17.
17. Stamler, J. S., D. I. Simon, J. A. Osborne, M. E. Mullins, O. Jaraki, D. J. Singel, and J. Loscalzo. 1991. S-nitrosylation of proteins by nitric oxide: synthesis and characterization of novel biologically active compounds. Proc. Natl. Acad. Sci. USA, 89:444-448.
18. Slamler, J. S., O. A. Jaraki, J. A. Osborne, D. I. Simon, J. F. Keaney, D. J. Singel, C. R. Valeri, and J. Loscalzo. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA, 89:7674-7677.
19. Stamler, J. S., D. I. Simon, O. Jaraki, J. A. Osborne, S. Francis, M. E. Mullins, D. J. Singel, and J. Loscalzo. 1992. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. USA. 89:8087-8091.
20. Keaney, J. F., D. I. Simon, J. S. Stamler, O. Jaraki, J. Scharfstein, J. A. Vita, and J. Loscalzo. 1993. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91:1582-1589.
21. Saville, B. 1958. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst. 83:670-672.
22. Byler, D. M., D. K. Gosser, and H. Susi. 1983. Spectroscopic estimation of the extent of S-nitrosothiol formation by nitrite action on sulfhydryl groups. J. Agric. Food Chem. 31:523-527.
23. Vester, B., and K. Rasmussen. 1991. High performance liquid chromatography method for the rapid and accurate determination of homocysteine in plasma and serum. Eur. J. Clin. Chem. Clin. Biochem. 29:549-554.
24. Palmer, R. M. J., D. S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond.). 333:664-666.
25. Lancaster, J. R., Jr., and J. B. Hibbs, Jr. 1990. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA. 87:1223-1227.
26. 2. Implications for the reaction of endothelium-derived relaxing factor (EDRF). Free Rad. Res. Comms. 10:221-226.
27. Bunton, C. A., D. R. Llewellyn, and G. Stedman. 1957. In Recent Aspects of the Inorganic Chemistry of Nitrogen. Special Publication No. 10, The Chemical Society, London, 113-120.
28. Downes, M. J., M. W. Edwards, T. S. Elsey, and C. L. Walters. 1976. Determination of a non-volatile nitrosamine by using denitrosylation and a chemiluminescence analyzer. Analyst. 101:742-748.
29. Pryor, W. A., and J. W. Lightsey. 1981. Mechanisms of nitrogen dioxide reactions: initiation of lipid peroxidation and the production of nitrous acid. Science (Wash. DC). 14:435-437.
30. Stamler, J. S., and J. Loscalzo. 1990. Nitrosylation of homocysteine as a novel antithrombotic mechanism. Clin. Res. 38:246a.
31. Ignarro, L. J., and C. A. Gruetter. 1980. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite. Biochim. Biophys. Acta. 631:221-231.
32. Gruetter, C. A., D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, and L. J. Ignarro. 1981. Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J. Pharmacol. Exp. Ther. 219:181-186.
33. Fung, H.-L., S. Chong, E. Kowaluk, K. Hough, and M. Kakemi. 1988. Mechanism for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine. J. Pharmacol. Exp. Ther. 245:524-530.
34. Chung, S., and H.-L. Fung. 1990. Thiol mediated catalysis of nitroglycerin degradation by serum proteins. Increase in metabolism was not accompanied by S-nitrosothiol production. Drug Metab. Dispos. 18:61-67.
35. Keaney, J. F., J. S. Stamler, J. Scharfstein, J. D. Folts, and J. Loscalzo. 1992. NO forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo. Clin. Res. 40:194A.
36. Keen, J. H., W. H. Habig, and W. B. Jakoby. 1976. Mechanism of the several activities of the glutathione S-transferases. J. Biol. Chem. 251:6183-6188.
37. Bennett, B. M., S. M. Kobus, J. F. Brien, K. Nakatsu, and G. S. Marks. 1987. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. J. Pharmacol. Exp. Ther. 237:629-635.
38. Tannenbaum, S. R., D. Fett, V. R. Young, P. D. Lang, and W. R. Bruce. 1978. Nitrite and nitrate are formed by endogenous synthesis in the human intestine. Science (Wash. DC). 200(4349):1487-1489.
39. Stamler, J. S., D. J. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science (Wash. DC). 258:1898-1902.
40. Jocelyn, P. C. 1972. Thiols and disulfides in blood. In Biochemistry of the SH Group. Academic Press Limited, London. 240-260.
41. Lewis, S. D., D. C. Misra, and J. A. Shafer. 1980. Determination of interactive thiol ionizations in bovine serum albumin, glutathione, and other thiols by potentiometric difference titration. Biochemistry. 19:6129-6137.
42. Mordvintsev, P. I., V. G. Rudneva, A. F. Vanin, L. L. Shimkevitch, and B. I. Khorodov. 1986. Inhibition of platelet aggregation by dinitrosyl iron complexes with low molecular weight ligands. Biokhimya. 51:1851-1857.
43. Malinski, T., and Z. Taha. 1992. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature (Lond.). 358:676-677.